US authorities on Monday lifted restrictions on the prescription and use of the anti-diabetes drug Avandia after a new study indicated it did not carry an elevated risk of heart attacks. The US Food and Drug Administration (FDA) announced the decision after considering the recommendations made by a...
![]()
![]()
![]()
![]()
![]()
↧